| Drug Name | Dabigatran etexilate |
|---|---|
| Other Drug Names | BIBR 953; BIBR 953 ZW; BIBR-1048; BIBR-1048MS; Dabigatran; Dabigatran etexilate mesilate; Dabigatran etexilate mesylate; Pradax; Pradaxa; Pradaxar; Prazaxa |
| Chemical Name | ethyl 3-[[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino]propanoate |
| Formula | C34H41N7O5 |
| Mol. Wt. | 627.74 |
| CAS No. | 211915-06-9 |
| UNII | 2E18WX195X |
| Target-based Actions | Factor IIa antagonist; Protease-activated receptor-1 antagonist |
| ATC Codes | B01AE07 |
| Highest Status | 2010年批准上市 |
| Originator Company | Boehringer Ingelheim Pharma GmbH & Co. KG and Bidachem S.p.A. |
| Structure |
 |